is a biotechnology company that specializes in the development of cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide. The company applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine to bring patient-specific therapies from the lab bench to the bedside.
02/16/2012 - Chairman's Blog
Timing and Pace of Our Clinical Trials
01/23/2012 - Company Blog
ACT Publishes First Report of Embryonic Stem Cell (ESC)-Derived Cells Transplanted Into Patients
May 9, 2012, 09:00 AM EDT
Conference Call: Q1 Results and Corporate Update
Click here to listen
April 26, 2012, 12:00 PM EDT
Annual Shareholders Meeting
Click here to listen
Jan. 9 - Jan. 11, 2012
Biotech Showcase 2012
Click here to access the ACT presentation (PDF)
Advanced Cell Technology Announces 2012 First Quarter Results
Annual Shareholders’ Meeting
April 26, 2012 (PDF)
Roth Capital 24th Annual Growth Stock Conference, March 14, 2012 (PDF)
Regenerative Medicine Track at Biotech Showcase 2012 (PDF)
Click here for our company profile (PDF)
Eye Study Is a Small but Crucial Advance for Stem-Cell Therapy - Technology Review
Blindness Eased by Historic Stem Cell Treatment - New Scientist